article · Langmuir
The release of common medications and illegal drugs into the environment could be potentially harmful to the ecosystem and hamper the behavior and growth of plants and animals. These pollutants gain access to water through sewage and factory discharges and have been found to exceed safety limits in water bodies. Therefore, there is an urgent need for improved wastewater purification systems. In this study, semiconductor-based heterojunction photocatalyst CuInS<sub>2</sub>/CeO<sub>2</sub>, synthesized through a facile solvothermal process, was explored for the photocatalytic degradation of ciprofloxacin, commonly used antibiotics. Studies on the electronic properties of the heterojunction revealed interfacial characteristics that were suitable for enhanced charge carrier separation and transport and a potential S-scheme charge transfer mechanism. The heterojunction achieved ∼90% efficiency for the degradation of CIP compared to 60% and 12% reported for CeO<sub>2</sub> and CuInS<sub>2</sub>, respectively. This shows an improvement in the activity, which results from the improved charge carrier properties of the heterojunction. Further investigation of the charge transfer mechanism through radical scavenging experiments identified <sup>•</sup>OH, O2<sup>•-</sup>, and h<sup>+</sup> as active species contributing to the catalyst's efficacy. Based on X-ray photoelectron spectroscopy analysis, a proposed S-scheme charge transfer mechanism was suggested for the CuInS<sub>2</sub>/CeO<sub>2</sub> heterojunction. The findings indicate the potential of the CuInS<sub>2</sub>/CeO<sub>2</sub> heterojunction as a promising photocatalyst for treating waste effluents from the pharmaceutical industry.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1021/acs.langmuir.4c04175
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.